3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
9
Multiple Myeloma
6
Lymphoma
5
Lung Neoplasms
5
Hematologic Neoplasms
3
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neurofibromatosis 2
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Endocrine Neoplasia Type 2a
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large-Cell, Anaplastic
1
Granuloma, Plasma Cell
1
Glioma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Interventions
atezolizumab
3
Specimen Handling
2
selinexor
1
pembrolizumab
1
pazopanib
1
fludarabine
1
cabozantinib
1
Radiotherapy
1
Radiation
1
Immunoglobulin G
1
Ifosfamide
1
Doxorubicin
1
Disulfides
1
Dactinomycin
1
Cyclophosphamide
1
Biopsy
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma, Alveolar Soft Part
×
Crizotinib
×
90 days
×
Clear all
No trials found.